¡i©ú³ø±M°T¡j¡m¥[®³¤jÂå¾Ç¨ó·|´Á¥Z¡n(Canadian Medical Association Journal)µoªí¤@¥÷·s¬ã¨s³ø§i¡M«ü¦Ñ¦~¤H²V¦XªA¥Î§Ü¥Í¯À§J©ÔÅð¯À(clarithromycin)©M¥L¥ÅÃþÃĪ«(statin)¡M´Nn«_§ó¤jªº·ÀI¡M¥i¯à¦³«æ©ÊµÇŦ·l®`¡M¨ä¥LÄY«°Æ§@¥Î¡C
¥[®³¤jÂå¥Í¤U³B¤èÃÄ¡M¶}±o³Ì¦hªº³B¤è¬O¥L¥ÅÃþÃĪ«¡M³oºØÃĪ«»Ýnªø´ÁªA¥Î¡M°§CÁx©T¾J¡C
¤Wz¬ã¨s³ø§i±Ä¥Î¬Ù«O°·¼Æ¾Ú®wªº«H®§¡M±´°Q¦w¬Ù2002¦~6¤ë¨ì2013¦~3¤ë´Á¶¡ªº¥ÎÃı¡ªp¡M66·³¤Î¥H¤Wªº¦Ñ¤H«ùÄòªA¥Î3ºØ¥L¥ÅÃþÃĪ«¤§¤@¡R·çµÎ¥ï¥L¥Å(rosuvastatin)¡B¬¥¥ï¥¦¥Å(fluvastatin)»P´¶¥ï¥L¥Å(pravastatin)¡M¨Ã¦P®É¨Ï¥Î¨âºØ±`¨£§Ü¥Í¯À¤§¤@¡R§J©ÔÅð¯À©ÎªüªÔÅð¯À(azithromycin)¡C
¬ã¨sµo²{¡M¦¨¤H¥»¨¤w¦³ªA¥Î¥L¥ÅÃþÃĪ«¡M¥[¤W³B¤èÃĪ«§J©ÔÅð¯À©ÎBiaxin XL¡M¤ñ¨Ï¥ÎªüªÔÅð¯À©ÎApo-Azithromycinªº¯f¤H¡M¦³§ó¤j·ÀI¡M¦]«æ©ÊµÇŦ·lÃa?¦å¹[¹L°ª¦Ó¦í°|¡C
¬ã¨s³ø§iªº¨ä¤¤¤@¦ì¸ê²`§@ªÌ¥[®æÂå¥Í(Dr. Amit Garg)»¡¡MÂå¥Í¤@¯ë¶}¥X§J©ÔÅð¯À©ÎªüªÔÅð¯À¡MªvÀø¦P¤@Ãþ·P¬V¯f¯g¡C
³o¬OÁp¦X¬ã¨s¡M¥Ñ¦w¬ÙÛ´°³Ò´Ë°·±d¬ã¨s°|(Lawson Health Research Institute)?Á{þHµû¦ô¬ì¾Ç¬ã¨s©Ò(Institute for Clinical Evaluative Sciences)¬ã¨sû¶i¦æ¡C
¥[®æ¦b±µ¨ü¥[®³¤j¼s¼½¤½¥q(CBC)¡m·s»D¡n(News)¸`¥Ø³X°Ý®É»¡¡M¬ã¨sµo²{¡M¦b¹L¥h10¦~¶¡¡MÂå¥Í¦P®É¶}¥X§J©ÔÅð¯À»P¥L¥ÅÃþÃĪ«¡M¦³5¸U¦¸¡C
¦b³o5¸U¦¸¤¤¡M¡u¼Æ¥H¦ÊpӮסvÅã¥ÜÄY«°Æ§@¥Î¡C¥L»¡¡M¨C100¦W¯f¤H¡M³Ì¦h¦³1¤H¨ü¼vÅT¡C
¥[®æ«ü¥X¡Mµ´¹ï·ÀI¬Û¹ï¸û§C¡M¬ù¦û1%¡C²V¥Î¨âºØÃĪ«¡M¦³¼ç¦b·ÀI¡Mì¦]¬O§J©ÔÅð¯ÀªýÂ_¬YºØ×Q(enzyme)¡M¦Ó¤HÅé»Ýn³oºØ×Q¤À¸Ñ¥L¥ÅÃþÃĪ«¡C¤Ö¤F¥¦¡M¦å¬yªº¥L¥ÅÃþÃĪ«§t¶q´N·|¼W¥[¡M²£¥Í³o¨Ç°Æ¤ÏÀ³¡C¥t¤@ºØ§Ü¥Í¯ÀªüªÔÅð¯À¡M¹ï³oºØ×Q¨S¦³¤zÂZ§@¥Î¡C